A detailed history of Asb Consultores, LLC transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Asb Consultores, LLC holds 953 shares of VRTX stock, worth $471,363. This represents 0.18% of its overall portfolio holdings.

Number of Shares
953
Previous 790 20.63%
Holding current value
$471,363
Previous $370,000 19.73%
% of portfolio
0.18%
Previous 0.13%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 30, 2024

BUY
$460.0 - $505.78 $74,980 - $82,442
163 Added 20.63%
953 $443,000
Q2 2024

Aug 12, 2024

SELL
$392.81 - $485.53 $183,835 - $227,228
-468 Reduced 37.2%
790 $370,000
Q1 2024

May 14, 2024

BUY
$407.69 - $446.08 $512,874 - $561,168
1,258 New
1,258 $525,000

Others Institutions Holding VRTX

About VERTEX PHARMACEUTICALS INC


  • Ticker VRTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 256,691,008
  • Market Cap $127B
  • Description
  • Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...
More about VRTX
Track This Portfolio

Track Asb Consultores, LLC Portfolio

Follow Asb Consultores, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Asb Consultores, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Asb Consultores, LLC with notifications on news.